Study of the neural substrates underlying deficits in executive function of murine models of intellectual disability. We are currently evaluating a mouse model of Down syndrome (Ts65Dn mice with partial trisomy equivalent to human chromosome 21). We also investigate potential beneficial actions on cognition of pharmacological treatments, natural compounds and environmental stimulation in this animal model.